Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Tetraphase Pharmaceuticals, Inc. (TTPH) and Encourages TTPH Investors to Contact the Firm NEW YORK, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Tetraphase Pharmaceuticals, Inc. (NASDAQ:...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tetraphase, GDS Holdings, and Sinclair and Encourages Investors to Contact the Firm NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Tetraphase Pharmaceuticals,...

Tetraphase Pharmaceuticals Appoints Kam Unninayar as Chief Financial Officer WATERTOWN, Mass., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. – TTPH NEW YORK, March 04, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Tetraphase...